SCHEMBL4674502

SCHEMBL4674502

Cc1cc(SC#N)c(N)cc1O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.41
USP8 P40818 1/20 0.41
USP5 P45974 1/20 0.41
USP4 Q13107 1/20 0.41
USP7 Q93009 1/20 0.41
ALDH1A1 P00352 6/20 0.37
MAPT P10636 4/20 0.37
HTT P42858 1/20 0.37
ALOX15 P16050 2/20 0.35
HSD17B10 Q99714 2/20 0.35
TSHR P16473 1/20 0.35
CASP1 P29466 1/20 0.35
PDE10A Q9Y233 1/20 0.35
KDM4E B2RXH2 2/20 0.34
HPGD P15428 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
G6PD P11413 1/20 0.34
CYP2C9 P11712 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2034128 0.82 ALDH1A1 (0.43) USP2USP8USP5USP4USP7
SCHEMBL4678827 0.78 HPGD (0.34) USP2USP8USP5USP4USP7
SCHEMBL4672913 0.78 ALDH1A1 (0.34) USP2USP8USP5USP4USP7
SCHEMBL11173991 0.77 USP2 (0.56) USP2USP8USP5USP4USP7
SCHEMBL10412909 0.75 USP2 (0.60) USP2USP8USP5USP4USP7
SCHEMBL8011042 0.75 ALOX15 (0.43) USP2USP8USP5USP4USP7
SCHEMBL4674061 0.75 EGFR (0.38) USP2USP8USP5USP4USP7
SCHEMBL4677750 0.75 ACHE (0.40) USP2USP8USP5USP4USP7
SCHEMBL4674203 0.75 ALDH1A1 (0.45) USP2USP8USP5USP4USP7
SCHEMBL16707477 0.73 USP2 (0.44) USP2USP8USP5USP4USP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1482935-B1 THIAZOLE AND OXAZOLE DERIVATIVES WHICH MODULATE PPAR ACTIVITY WARNER LAMBERT CO (US) 2008-08-20 EP disclosed
EP-1482935-B1 THIAZOLE AND OXAZOLE DERIVATIVES WHICH MODULATE PPAR ACTIVITY WARNER LAMBERT CO (US) 2008-08-20 EP disclosed
EP-1482935-A1 THIAZOLE AND OXAZOLE DERIVATIVES WHICH MODULATE PPAR ACTIVITY Warner-Lambert Company LLC (US) 2004-12-08 EP disclosed
US-20030207924-A1 Compounds that modulate PPAR activity and methods of preparation CHENG XUE-MIN (US) 2003-11-06 US disclosed
WO-2003074050-A1 THIAZOLE AND OXAZOLE DERIVATIVES WHICH MODULATE PPAR ACTIVITY WARNER-LAMBERT COMPANY LLC (US) 2003-09-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030207924-A1 Compounds that modulate PPAR activity and methods of preparation PPARA, PPARD, PPARG USP2 3457/4885USP8 3178/4885USP5 2912/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.